Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Lung Neoplasms × alectinib × Clear all

Status

Sponsor Class

Study Type

Interventional 6 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Sexual Dysfunction, Physiological 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Eunuchism 1 Erectile Dysfunction 1 Disease Resistance 1 ALK-positive NSCLC 1

Interventions

Blood Specimen Collection 32 Surveys and Questionnaires 24 Radiotherapy 12 Gene Expression Profiling 12 Drug Therapy 12 Surgical Procedures, Operative 11 Bronchoscopy 10 Magnetic Resonance Spectroscopy 9 Immunotherapy 9 Immunohistochemistry 9 Specimen Handling 8 Amplified Fragment Length Polymorphism Analysis 8 Tomography, X-Ray Computed 7 Polymerase Chain Reaction 7 Observation 7 pembrolizumab 6 Psychiatric Rehabilitation 6 Interviews as Topic 6 Carboplatin 6 Thoracic Surgery, Video-Assisted 5 Reverse Transcriptase Polymerase Chain Reaction 5 Microarray Analysis 5 Liquid Biopsy 5 Chemoradiotherapy 5 Bevacizumab 5 durvalumab 4 Therapeutics 4 Paclitaxel 4 Nivolumab 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04708639 2021-02-02

MonAlec

Aarhus University Hospital

Lung Neoplasms, Disease Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡